Key Agents and Pharmacological Profiles: Since the first GLP-1 analog was approved in 2005, multiple agents have been developed, varying in structure, receptor selectivity, dosing frequency, and clinical applications
Rosenstock and colleagues examined the type 2 diabetes Phase 2 in The Lancet comparing retatrutide against placebo and an active comparator on glycemic and weight endpoints (PMID 37385280)
Also, many times, the side effects of one drug are not tolerated by the patient and then I will switch them to the other. In addition, supply issues that affect the availability of a specific medication which were a factor when this study was done can determine which one will be prescribed
Trulicity: Key differences The key difference between Wegovy and Trulicity is that they contain different active ingredients
Prioritize fluid intake before, during, and after physical activity